Treatment of visceral leishmaniasis with sterically stabilized liposomes containing camptothecin

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 9, 2001, Pages 2623-2627

  Proulx, M E ^a   Desormeaux A ^a   Marquis, J F ^a   Olivier, M ^a   Bergeron, M G ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; LIPOSOME;

ANEMIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; LEISHMANIA DONOVANI; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIPROTOZOAL AGENTS; CAMPTOTHECIN; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIPOSOMES; MICE; MICE, INBRED BALB C; TREATMENT OUTCOME;

EID: 0034862972     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.9.2623-2627.2001     Document Type: Article

References (27)

1. Long-circulating (sterically stabilized) liposomes for targeted drug delivery
2. Subcutaneous administration of liposomes: A comparison with the intravenous and intraperitoneal routes of injection
3. Estimation of population at risk of infection and number of cases of leishmaniasis
4. Liposomes in the treatment of parasitic, viral, fungal and bacterial infections
5. Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1
6. Drug cytotoxicity assay for African trypanosomes and Leishmania species
7. Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: Efficacy and mode of action
8. Lipid bilayer partitioning and stability of camptothecin drugs
9. Liposomal stabilization of camptothecin's lactone ring
10. Liposomal amphotericin B in the treatment of visceral leishmaniasis
11. Liposomes as drug delivery system: A strategic approach for the treatment of HIV infection
12. Lymphoid tissues targeting of liposome-encapsulated 2′,3′-dideoxyinosine (ddI)
13. Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells
14. Camptothecin inhibits both the cleavage and religation reactions of eukaryotic DNA topoisomerase I
15. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions
16. Inhibition of Leishmania class I DNA topoisomerase by minor groove-binding ligands: Effect on parasite growth and cell cycle
17. Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis
18. Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine leishmaniasis progression
19. Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani
20. Liposomal encapsulation of 3′-azido-3′-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosuppression
21. Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome
22. Diospyrin, a bisnaphthoquinone: A novel inhibitor of type I DNA topoisomerase of Leishmania donovani
23. Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11
24. The past, present, and future uses of liposomes in treating infectious diseases
25. The H circles of Leishmania tarentolae are a unique amplifiable system of oligomeric DNAs associated with drug resistance